Upcoming webcast: Liquid Biopsies in Clinical Oncology

On June 11th, Nature Cancer and Nature Biotechnology editors are organising a webinar on the current trends in applications of liquid biopsies in cancer diagnosis, prognosis and therapy and the features of robust liquid biomarkers.

Published in Cancer

Upcoming webcast: Liquid Biopsies in Clinical Oncology
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

On June 11th, Nature Cancer and Nature Biotechnology editors are organising a webinar on the current trends in applications of liquid biopsies in cancer diagnosis, prognosis and therapy and the features of robust liquid biomarkers.

Speakers:

  • Caroline Dive, Professor at the Cancer Research UK National Biomarker Centre, Cancer Research UK Manchester Institute & Cancer Research UK National Biomarker Centre
  • Lillian Siu, Professor at Medical Oncology and Hematology, University of Toronto and Princess Margaret Cancer Centre

 Chaired by: Eleni Skourti, Senior Editor at Nature Cancer and Barbara Cheifet, Chief Editor at Nature Biotechnology

Date and time: Wednesday, June 11th, 3pm UK time/10am ET

 Join via link: https://cassyni.com/events/5evgfsJt5tQyTywGypPR8h?83xp2

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Follow the Topic

Oncology
Life Sciences > Health Sciences > Clinical Medicine > Oncology

Related Collections

With Collections, you can get published faster and increase your visibility.

Cancer Neuroscience: from mechanisms to therapy

With this collection, Nature Communications, Nature, Nature Cancer, Nature Neuroscience, Nature Progress Oncology, Nature Progress Brain Health, and Communications Biology invite submissions that aim to elucidate the molecular mechanisms underlying bidirectional cancer–nervous system interactions and their influence on the tumour microenvironment, as well as pre-clinical and clinical studies exploring potential therapeutic strategies to target neural–cancer interactions.

Publishing Model: Hybrid

Deadline: Jan 30, 2027